Effect of defibrotide on platelet function

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue SUPPL. 1, 1996, Pages 21-24

  Ulutin, Orhan N ^a   Balkuv Ulutin, Şengün ^b   Bezer Göker, Bahar ^b   Çizmeci, Günay ^b   Ferhanoǧlu, Burhan ^b   Ozsoy, Yildiz ^b   Uǧur, Musa Ş ^b   Ulutin, Turgut ^b   Yaman, Azize ^b   Yardimci, Turay ^b  

^a Levent   (Turkey)

^b NONE

Author keywords

Defibrotide; Membrane transport; Platelet glutamyl transferase; Platelet adhesion,; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ANTICOAGULANT AGENT; BETA THROMBOGLOBULIN; CARBON 14; COLLAGEN; CYCLIC AMP; DEFIBROTIDE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEPARIN; MALONALDEHYDE; POLYDEOXYRIBONUCLEOTIDE; PROSTACYCLIN; THROMBOCYTE FACTOR 4; THROMBOXANE B2; TISSUE PLASMINOGEN ACTIVATOR;

ATHEROSCLEROSIS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG MECHANISM; DRUG POTENTIATION; GLUCOSE TRANSPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOEMBOLISM; VASCULITIS;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; BLOOD PLATELETS; PLATELET AGGREGATION; POLYDEOXYRIBONUCLEOTIDES; RATS;

EID: 9444293357     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Çizmeci G, ON Ulutin: Defibrotide: Antithrombotic effect existing from modified endothelium functions. XXth Congress of ISH, September 1-7, 1984, Buenos Aires (Abst 824).
2. Çizmeci G, ON Ulutin: Corrective effect of defibrotide on altered endothelium cell function in atherosclerosis. Thromb Hemostas 54:87(P 515), 1985.
3. Çizmeci G: In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels. Haemostasis 16(Suppl 1):31-35, 1986.
4. Ulutin ON, Ş Balkuv-Ulutin, MŞ Uǧur, T Ulutin, T Erbengi, B Ferhanoǧlu, T Yardimci: Defibrotide and its effect on platelet functions. In: Sinzinger H, H Vinazzer (Eds): Thrombosis and Haemorrhagic Disorders. Schmit and Meyer GmbH, Würzburg, 1989, pp 426-428.
5. Löbel P, F Asai, K Schrör: Ten fold increase in platelet c-AMP by defibrotide in the platelet-perfused in vitro heart. VIth International Conference on Prostaglandins, Florence, June 3-6, 1986, p 427.
6. Uǧur MŞ: Defibrotide' in trombosit Ultrastrüktürüne etkisi (The effect of defibrotide on platelet ultrastructure). Ph.D. Thesis, Istanbul, Univ. Saǧlik Bilimleri Enstitüsü Istanbul, 1986.
7. Ulutin ON, G Çizmeci, Mş Uǧur: Clinical pharmacology of defibrotide and its effect on platelet function. Haemostasis 18(Suppl 2):143-149, 1988.
8. Ozer AF, MN Pamir, T Erbengi, ON Ulutin: The effect of defibrotide on thrombosis formation in microarterial anastomoses. International World Congress of Neurological Surgery, New Delhi, October 8-13, 1989.
9. Ozer AF, PM Pamir, T Erbengi, ON Ulutin: The effect of defibrotide on platelet thrombus formation in microarterial anastomoses. J Thromb Haemorrh Disorders 1:67-72, 1990.
10. Ulutin ON, H Tunali, G Girişken, Ş Aytiş, MŞ Uǧur, Ş Balkuv-Ulutin: The effect of "Fraction P" on the electrically induced thrombus formation in dogs. Haemostasis 12:130, 1982.
11. Ulutin ON, H Tunali, MŞ Uǧur, Ş Aytiş, T Erbengi, Ş Balkuv-Ulutin: Effect of defibrotide in electrically induced thrombosis in dogs. Haemostasis 16(Suppl 1):9-12, 1986.
12. Thiemermann C, P Löbel, K Schrör: Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol 56:978-982, 1985.
13. Löbel P, M Palmer, K Schrör: Changes in platelet reactivity, prostacyclin and thromboxane production after long-term oral defibrotide in healthy and atherosclerotic rabbits. In: Sinzinger H, K Schrör (Eds): Prostaglandins in Clinical Research. Ries, New York, 1987, pp 265-270.
14. Löbel P, K Schrör: Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits. Atherosclerosis 80:69-79, 1989.
15. Coccheri S, G Prino, F Grauso, C Legnani, M Mantovani, G Piagi: Defibrotide: An experimental antithrombotic agent. In: Davidson JF, MB Donati, S Coccheri (Eds): Progress in Fibrinolysis VII. Churchill-Livingstone, Edinburgh, 1985, pp 81-85.
16. Gryglewski RJ, E Marcinkiewicz, M Radomski, J Swies: Prostacyclin and the mechanism of action of defibrotide. Eicosanoids 2:163-167, 1989.
17. Breddin HK, K Krupinski, J Fareed: On the effect of defibrotide on platelet function, coagulation on thrombus formation in rat mesenteric arterioles or venules after laser injury. Thromb Haemostas 62:429 (Abst 1377), 1989.
18. Ulutin ON, G Çizmeci, Ş Balkuv-Ulutin: Clinical pharmacology and mode of actions of new antithrombotic compound: defibrotide. Folia Haematol 115:177-180, 1988.
19. Ulutin ON: The clinical and pharmacological results of defibrotide during the treatment of POVD. In: Strano A, S Novo (Eds.): Advances in Vascular Pathology. Excerpta Medica, Amsterdam, 1990, pp 157-162.
20. Ulutin ON, Ş Balkuv-Ulutin, MŞ Uǧur, T Ulutin, Y Ozsoy, G Çizmeci: The pharmacology and clinical pharmacology of defibrotide: A new profibrinolytic, antithrombotic and antiplatelet substance. In: Lie CY, S Chien (Eds): Fibrinogen, Thrombosis, Coagulation and Fibrinolysis, Advances in Experimental Biology Series. Plenum, New York, 1991, pp 429-438.
21. Rebuck JW, JM Riddle, MJ Brown, SA Johnson, RW Monto: Volumetric and ultrastructural studies of abnormal platelets. In: Johnson SA, RW Monto, JW Rebuck, RC Horn (Eds): Blood Platelets. Little, Brown, Boston, 1961, pp 533-552.
22. Arosio E, P Pancera, M Zannoni, G Arcaro, F Priante, A Lechi: Defibrotide and peripheral obliterative arterial disease: Preliminary data. Int J Clin Pharmacol Ther Toxicol 27:526-529, 1989.
23. Ulutin ON: The Platelets: Fundamentals and Clinical Applications. Kaǧit ve Basim Işleri AŞ, Istanbul, 1976.
24. Ulutin ON: Haemostasis and atherosclerosis. In: Poller, L (Ed): Recent Advances in Blood Coagulation 5. Churchill-Livingstone, Edinburgh, 1991, pp 53-77.
25. Göker-Bezer B, T Yardimci, ON Ulutin: The correcting effect of defibrotide on the defective platelet glucose transport in atherosclerotic subjects. Second Mediterranean Congress of Angiology (Abst 119), Antalya, September 16-21, 1990.
26. Göker B, T Yardimci, ON Ulutin: Isolation of glucose transporter from human platelets and restoration of the impaired platelet active transport of glucose in atherosclerotics with defibrotide. Thromb Haemostas 65:1096 (Abst 1441), 1991.
27. Ozer NK, U Oncel, ON Ulutin, K Emerk: Defibrotidin aterosklerotik hastalarin eritrosit glukoz taşimina etkisi (The effect of defibrotide on glucose transport of red cells obtained from atherosclerotic patients). XXII Ulusal Hematoloji Kongresi, Istanbul, October 21-25, 1991.
28. 14C-glucose membrane transportuna etkisi. XXII. Ulusal Hemstoloji Kongresi, Istanbul, October 21-25, 1991.
29. Yardimci T, A Yaman, ON Ulutin: γ-Glutamyl transferase and gluthione levels in platelets of normal and atherosclerotic subjects. XIth International Congress on Thrombosis (Abst 33), Ljubljana, June 24-28, 1990.
30. Yardimci T, ON Ulutin: Alteration of platelet glucose transport system in atherosclerosis. Wien Klin Wochenschr 98:221-224, 1986.
31. Yardimci T, A Yaman, ON Ulutin: The levels of γ-glutamyl transferase and glutathione in platelets of normal and atherosclerotic subjects before and after defibrotide. Second Mediterranean Congress of Angiology (Abst 326), Antalya, September 16-21, 1990.
32. Yardimci T, A Yaman, ON Ulutin: Characterization of platelet gamma glutamyl transferase and its alteration in cases of atherosclerosis. Clin Appl Thromb Hemostas 1:103-113, 1995.